Bharat Biotech's nasal vax priced at Rs 800 for private markets

Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs 800 (excluding GST) for private markets and Rs......

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

The Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years. "Big Boost to India's Fight......

Bharat Biotech's nasal Covid vaccine iNCOVACC launched

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.......

Study comparing Covishield, Covaxin has limitations: Bharat Biotech

Raches Ella, project lead, Covid-19 vaccines at Bharat Biotech said in a series of tweets that he was ‘surprised’ that media and researchers were drawing conclusions based on non-peer......

'I'm willing to give more than Rs 35,000 crores for vaccines'

'I'll give it to the vaccine manufacturers without guarantees, take the payment in advance and give me the supplies.''The moment you give me one lot of supply, I'll give you more.' IMAGE: A......

Markets ended flat amid a volatile trading session

The markets ended flat amid a volatile trading session on Monday after elections for the 16th Lok Sabha kicked off today. Meanwhile, Sun Pharma and Ranbaxy Labs hogged the limelight after Sun......

PE not for small-ticket HNIs

Bharat Banka, Managing Directorand CEO, Aditya Birla Private Equity, is delighted with high net-worth individuals' rising interest in private equity. With expected returns of 25-30 per cent......

'Few FCCB re-pay options for India Inc'

Only five Indian companies would be in a position to choose most available redemption options for their foreign currency convertible bonds (FCCBs), due for redemption this year, according to a......